Long-Term Effects of Metformin on Endothelial Function in Type 2 Diabetes: A Randomized Controlled Trial

de Jager, J., Kooy, A., Schalkwijk, C., van der Kolk, J., Lehert, P., Bets, D., Wulffelé, M. G., Donker, A. J., Stehouwer, C. D. A.·2014·Journal of Internal Medicine
DOI 10.1111/joim.12128

Cited by (129)

Items 101–129 of 129

  1. Attenuation of Endothelial Dysfunction in Diabetes Mellitus: An Integral Characteristic of Anti-Diabetic Medications
    Chidiebere Valentine Ugwueze · 2025 · Journal of Diabetology
  2. Insulin, Other Hypoglycemic Drugs, and Glucagon
    Alisa K. Escaño · 2015 · Side effects of drugs annual
  3. Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes
    Wei‐Wei Ye, Yi Wang, Feng Chen, Qian Zhao, Xiangying Meng, Jianyang Chen, Cong Liu, Yong Zhou · 2022 · Journal of Healthcare Engineering · Retracted
  4. Glucose Metabolism, Diabetes, and the Arterial Wall
    Coen D.A. Stehouwer, Isabel Ferreira, M. Kozàkovà, Carlo Palombo · 2015 · Elsevier eBooks
  5. Metformin: od mehanizmov delovanja do napredne klinične uporabe
    Miodrag Janić, Špela Volčanšek, Mojca Lunder, Andrej Janež · 2017 · Slovenian Medical Journal
  6. Metformin Sensitizes Leukemic Cells to Cytotoxic Lymphocytes by Increasing Expression of Intercellular Adhesion Molecule-1 (ICAM-1)
    Nerea Allende-Vega, Joaquín Marco-Brualla, Paolo Falvo, Catherine Alexia, Michael Constantinides, Alexis Fayd’herbe de Maudave, Loïs Coënon, Delphine Gitenay, Giulia Mitola, Paul E. Massa et al. · 2021 · Research Square
  7. Metformin Sensitizes Leukemic Cells to Cytotoxic Lymphocytes by Increasing Expression of Intercellular Adhesion Molecule-1 (ICAM-1)
    Nerea Allende-Vega, Joaquín Marco-Brualla, Paolo Falvo, Catherine Alexia, Michael Constantinides, Alexis Fayd’herbe de Maudave, Loïs Coënon, Delphine Gitenay, Giulia Mitola, Paul E. Massa et al. · 2021 · Preprints.org
  8. Controversial effects of metformin on human physiology and pathophysiology
    Shuo Fang, Qirui Liu, Yi Lu, Jian Zhang · 2026 · Frontiers in Pharmacology
  9. Lower Cardiovascular Risk with Diabetic Drugs: A Paradigm Shift from Glucocentricity to Cardio Protectiveness
    Bijaya Mohanty · 2017 · Diabetes Case Reports
  10. Cardiovascular Effects of Metformin
    B. T. Kurmanbekova, A. M. Noruizbaeva · 2022 · Rational Pharmacotherapy in Cardiology
  11. Metformin alters signaling induced crosstalk and homeostasis in the carcinogenesis paradigm “Epistemology of the origin of cancer”
    Björn L.D.M. Brücher, Ijaz S. Jamall · 2019 · 4open
  12. Metformin: A Small Molecule with Multi-Targets and Diverse Therapeutic Applications
    Adel Farid Badria, Ahmed R. Ali, Ahmed Elbermawi, Yhiya M. Amen, Adel Farid Badria · 2022 · IntechOpen eBooks
  13. The Role of a Deglycating Enzyme ‘Fructosamine-3-Kinase’ in Diabetes and COPD.
    Amr Alderawi · 2017 · Wolverhampton Intellectual Repository and E-Theses (University of Wolverhampton)
  14. Metformin Sensitizes Leukemic Cells to Cytotoxic Lymphocytes by Increasing Expression of Intercellular Adhesion Molecule-1 (ICAM-1)
    Nerea Allende-Vega, Joaquín Marco-Brualla, Paolo Falvo, Catherine Alexia, Michael Constantinides, Alexis Fayd’herbe de Maudave, Loïs Coënon, Delphine Gitenay, Giulia Mitola, Paul E. Massa et al. · 2021 · Research Square
  15. Análise do papel da metformina na via insulínica, não-insulínica e inflamatória
    Leonardo Gomes Peixoto · 2015
  16. Affect of late-onset prenatal care on antenatal diagnosis.
    Joann Norma Bodurtha, L Corey, Walter E. Nance · 1986 · PubMed
  17. Diabetes and the Cardiovascular System
    Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro · 2018 · Endocrinology
  18. Metformin – nichtglykämische Wirkungen
    Hans‐Georg Joost · 2021 · Der Diabetologe
  19. Metformin – nichtglykämische Wirkungen
    Hans‐Georg Joost · 2021 · Der Kardiologe
  20. Diabetes and the Cardiovascular System
    Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro · 2018 · Endocrinology
  21. Diabetes and the Cardiovascular System
    Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro · 2020 · Endocrinology
  22. Diabetes and the Cardiovascular System
    Mauro Rigato, Gian Paolo Fadini, Angelo Avogaro · 2019 · Endocrinology
  23. Pulmonary thromboembolism and diabetes mellitus
    Lilia David · 2022 · Bulletin of the Academy of Sciences of Moldova Medical Sciences
  24. Pathogenetic basis of treating endothelial dysfunction with metformin in patients with diabetes (literature review and own data)
    A.M. Sokolova, VIKTOR V. PUSHKAREV, LIUBOV K. SOKOLOVA, V.M. Pushkarev, Mykola D. Tronko · 2024 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
  25. Effect of extended-release metformin on humoral cardiometabolic markers and lipid peroxidation parameters in patients with prediabetes, heart failure with preserved ejection fraction and abdominal obesity
    Цыганкова Оксана Васильевна, N. E. Apartseva, Lydmila D. Latyntseva, Yа. V. Polonskaya, Elena Vladimirovna Kashtanova · 2024 · CARDIOVASCULAR THERAPY AND PREVENTION
  26. Public Health Insights into Cardiovascular Risks among Diabetic Patients: Evaluating the Individual and Combined Effects of Amlodipine and Metformin
    James Watt, Zahidullah, Ali Raza Sandhu, Misbah Zakir Abowath, Aisha Alamgir · 2025 · Indus journal of bioscience research.
  27. Metformin for endothelial dysfunction in non-diabetic disorders: a scoping review
    Roland van Rensburg, Anel Schoonees, Mohammed Wulgo Ali, Gert Uves van Zyl, Eric H. Decloedt · 2025 · BMJ Open
  28. Dose-Dependent Association of Long-Term Metformin Use and Diabetic Nephropathy Risk in Patients with Type 2 Diabetes Mellitus: A Nationwide Population-Based Study in Taiwan
    Kuang‐Hua Huang, Shuo‐Yan Gau, Yu-Chia Chang, Zong-Han Lin, Tung‐Han Tsai, Ya-Lan Chang, Chien‐Ying Lee · 2026 · Clinical Drug Investigation
  29. Effect of glucose-lowering therapy on the course of the wound healing process in patients with type 2 diabetes mellitus and/or obesity
    M. O. Gurba, В. В. Салухов · 2026 · Russian Military Medical Academy Reports